Study Suggests Hospitals Do Not Follow Recommendations for Bed Cleaning Products
For the study, researchers queried 113 hospitals ranked by US News & World Report about their cleaning procedures for hospital beds and mattresses. Of these, 69 (61 percent) agreed to participate in the survey. They were asked questions ranging from what chemicals they use to clean their beds and mattresses to how the cleaner is rinsed off the bed. Key findings from the survey include the following:
• 84 percent of hospitals use quaternary ammonia compounds to clean hospital beds. These chemicals have been tested on hard surfaces only and do not have EPA approval for use on soft surfaces such as hospital mattresses.
• Only 23 percent of these hospitals cleaned the mattress surface prior to using the disinfectant, as is recommended by both the bed and chemical manufacturers.
• Only 6 percent of these hospitals rinsed the chemical disinfectant away after disinfection, as recommended by the bed manufacturers, since patients could be exposed to residual disinfectant.
• Only two hospitals were using disinfectants with a pH balance recommended by the bed and fabric manufacturers.
The research was presented on Monday at the annual meeting of the Association for Professionals in Infection Control and Epidemiology in San Antonio.
Related Articles on Disinfection:
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Participants race to increase colon cancer awareness during 2017 Greater Chattanooga Rump Run 5K and Fun Walk: 4 takeaways
- US woman dies from superbug resistant to 26 antibiotics — 8 things to know
- Healthcare nanotechnology market to grow at a CAGR above 12% till 2024
- American Anesthesiology to exhibit at ASA's Practice Management 2017: 3 things to know
- Gastroenteropancreatic neuroendocrine tumor patients utilize combination therapy: 5 study insights